Dr. Gail Lebovic MA, MD, FACS
CEO & Founder
Dr. Lebovic has committed her career to improving the delivery of healthcare for patients around the world. Internationally recognized for her groundbreaking work as an Oncoplastic Surgeon, Dr. Lebovic is also highly regarded as a creative inventor and successful serial entrepreneur.
Along with her highly skilled team, she has developed numerous innovative products, successfully bringing them to market alongside strategic partners. The team’s success is second to none with multiple successful acquisitions totaling nearly $500M, with the most recent being Hologic’s $125 million acquisition of Focal Therapeutics. Page two lists a number of companies founded by Dr. Lebovic.
Dr. Lebovic’s pioneering work has garnered widespread recognition, most recently earning her the Stevie Award for Most Innovative Woman of the Year for Healthcare in 2024. This marks her third consecutive Women in Business Stevie Award, following a Gold win in 2023 as Female Innovator of the Year and a Bronze in 2022 for Women Leaders in Business. She was also awarded the 2023 Women in Innovation Award for Leadership. In 2021 she was presented with the Monumental Alumni Award – the highest form of recognition given to a select group of elite graduates from George Washington University.
Additionally, Dr. Lebovic received the prestigious Pathfinder Lifetime Achievement Award, shared by Global pioneers in healthcare, Professor Umberto Veronesi, Dr. Laszlo Tabar and others. In addition to these highly merited awards, she was presented with the Spirit of Achievement Award from the American Cancer Society in 2012 recognizing her talents as a skilled clinician, inventor and entrepreneur.
Currently, Dr. Lebovic serves as Founder and CEO of Silicon Valley Innovations, Inc. The company is focused on bringing novel drug delivery platforms to the multi-billion dollar nasal healthcare and feminine healthcare markets. The team’s new products span the clinical spectrum of drug delivery from simple OTC antiseptics to other OTC drugs aimed at specific clinical conditions. Their initial product brings NasoClenz to market as the first intranasal antiseptic for use by the 155 million consumers seeking nasal relief products. NasoClenz was created to dominate the nasal healthcare market targeting patients with allergies, chronic sinus issues, CPAP users and more.
Dr. Lebovic holds over 50 US patents, is a member of the Forbes Business Council and continues to innovate ground-breaking, “first-in-class” products to improve the lives of people globally. Her unique signature is her passion for creating products that are comfortable, cost-effective and designed for easy adoption by users. She has served as director of several important clinical programs and is the Founder of the Society of Oncoplastic Surgery, a designated 501c3 non-profit organization. Dr. Lebovic is a passionate patient advocate and remains involved in Global philanthropic and educational efforts spanning various aspects of healthcare and innovation.